The Innovation in Mitral Valve Repair Treatment, Australian & New Zealand Lower MR Grades e-Course is coming soon.
This meeting will begin shortly. Please follow the below instructions:
1. Please wait until the designated time for this e-Course. At the starting time, click the red button below
2. When you click the button below, you will be prompted to open the Zoom app or join via webpage. For best user experience, click ‘Join via Zoom app’
3. Enter your name and email to enter
Webinar ID: 818 6288 1155
Dr Chris Raffel is an Interventional Cardiologist whose clinical interests include transcathter heart valve therapies and structural heart disease management. Dr Raffel did his Cardiology training at GreenLane Hospital, Auckland, New Zealand and completed Fellowships at the Massachusetts General Hospital and Harvard Medical School in Boston, USA.
Dr Raffel is now located in Queensland, Australia with appointments as the Acting Director of Cardiac Catheterisation, The Prince Charles Hospital, and as an Associate at the CardioVascular Clinics, St Andrew’s War Memorial Hospital.
His current academic appointments include Professor (Adjunct), School of Mechanical, Medical & Process Engineering, Faculty of Science & Engineering, Queensland University of Technology and Associate Professor, Faculty of Medicine, The University of Queensland.
Professor Neal Uren is the Senior Director for Professional Education & Medical Affairs at TMTT, Edwards Lifesciences in Nyon, Switzerland. Until May 2021, he was a consultant cardiologist at the Edinburgh Heart Centre, Royal Infirmary, Edinburgh and, since 2017, the Professor of Interventional Cardiology at the University of Edinburgh. He was appointed as a consultant in 1997. He was Clinical Director of Cardiac Services from 2011-7 and continued as director of the TAVI service. In 2017, he set up the national percutaneous mitral valve repair service in Scotland becoming the first centre there to perform a transcatheter mitral valve replacement.
A graduate of the University of Edinburgh in 1984, Professor Uren trained in Cardiology at the Hammersmith Hospital and the Royal Free Hospital in London, and at the Glenfield Hospital in Leicester. He also completed a fellowship in interventional cardiology at Stanford University School of Medicine, Stanford, USA. During his time at the MRC Cyclotron Unit at Hammersmith Hospital, he completed an MD thesis with Honours on coronary resistive vessel function in coronary disease using invasive techniques and positron emission tomography.
He has participated as principal investigator in numerous large, multi-national studies and has authored or co-authored over 80 scientific papers in peer-reviewed journals. He is one of the few physicians in the UK to hold Level 3 accreditation in CT coronary angiography from the Society of Cardiac Computed Tomography.
Dr Andreas Rück is a Cardiologist located in Sweden who specialises in Interventional Cardiology including percutaneous coronary intervention and percutaneous valve implantation such as transcatheter valve therapy. Dr Rück completed a PhD focusing on ‘Myocardial gene therapy and gene expression in angina pectoris’ with the Karolinska University Hospital and Huddinge University Hospital in Sweden.
Dr Rück is the Head of TAVI Program at the Karolinska University Hospital and Chairman of the Swedish Percutaneous Valve Registry. He is also actively involved in the Working Group for PCI and Valve Interventions within the Swedish Society of Cardiology.
Professor Holger Nef is an Interventional Cardiologist specialising in coronary artery diseases, intravascular imaging and structural heart disease. He has received the Brettschneider Prize from the German Cardiac Society and the Becht Research Prize from the German Heart Research Foundation.
Professor Nef is currently the Associate Director and Interventional Cardiologist at University of Gießen.
Dr Raj Nair is an Interventional Cardiologist with a special interest in structural heart disease intervention, clinical cardiology and clinical governance. He is the Deputy Chair of the Cardiac Intervention and Device Committee at Pharmac and is the Co-Founder of Structural Heart Disease Asia Pacific. He is also on the Organising Committee for ANZET Meeting focusing on Interventional Cardiology for the CSANZ. Dr Nair is also on multiple advisory boards which allow him to collaborate with various professionals and successfully lead heart teams, performing first-in-man therapies in Zurich and Madrid.
Dr Nair is located in Waikato, New Zealand with appointments at Waikato Hospital, Southern Cross Heart Institute and Midland Cardio Vascular Services.
Mitral valve repair
The PASCAL platform is designed for predictable capture, positioning and release in patients with MR. The recently introduced PASCAL Ace implant expands your treatment options, allowing you to tailor the procedure to your needs. PASCAL Ace provides a narrow profile designed to improve ease of subvalvular navigation.
Effectively reduces mechanical strain on the leaflets, avoiding areas of stress concentration
Single-row retention element orientation designed to reduce the risk of leaflet damage even with multiple recapturing
Spring based passive-closing system respects native anatomy
Watch how it works
| Mitral valve repair with PASCAL and PASCAL Ace